Proto Labs, Inc.
PRLB
$90.80
$0.350.39%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 560.54M | 546.26M | 533.13M | 518.38M | 508.64M |
| Total Other Revenue | -- | 185.00K | 419.00K | 625.00K | 906.00K |
| Total Revenue | 560.54M | 546.26M | 533.13M | 518.38M | 508.64M |
| Cost of Revenue | 305.94M | 301.23M | 295.99M | 289.66M | 283.98M |
| Gross Profit | 254.60M | 245.03M | 237.14M | 228.72M | 224.66M |
| SG&A Expenses | 171.17M | 169.32M | 168.13M | 163.99M | 161.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 519.47M | 513.29M | 506.93M | 495.83M | 486.36M |
| Operating Income | 41.07M | 32.97M | 26.20M | 22.55M | 22.28M |
| Income Before Tax | 42.32M | 36.39M | 31.06M | 22.63M | 22.25M |
| Income Tax Expenses | 11.85M | 10.64M | 9.82M | 7.79M | 7.43M |
| Earnings from Continuing Operations | 30.48 | 25.75 | 21.24 | 14.84 | 14.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.48M | 25.75M | 21.24M | 14.84M | 14.81M |
| EBIT | 41.07M | 32.97M | 26.20M | 22.55M | 22.28M |
| EBITDA | 74.11M | 66.49M | 60.34M | 57.40M | 57.61M |
| EPS Basic | 1.28 | 1.08 | 0.89 | 0.62 | 0.61 |
| Normalized Basic EPS | 1.22 | 1.02 | 0.84 | 0.74 | 0.71 |
| EPS Diluted | 1.25 | 1.06 | 0.88 | 0.61 | 0.60 |
| Normalized Diluted EPS | 1.20 | 1.01 | 0.83 | 0.73 | 0.71 |
| Average Basic Shares Outstanding | 95.45M | 95.39M | 95.69M | 96.40M | 97.49M |
| Average Diluted Shares Outstanding | 97.06M | 96.75M | 96.90M | 97.20M | 98.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |